IVP Ltd

IVP Limited's capital structure shows a debt-to-equity ratio of 0.75, indicating a moderate reliance on debt financing. The company's liquidity position is characterized by a current ratio of 1.32, suggesting it has sufficient short-term assets to cover its short-term liabilities. However, the operating cash flow is negative at -24.7 million INR, which may raise concerns about its ability to generate cash from operations. In terms of profitability, IVP Limited's return on equity (ROE) is 8.12%, and its return on assets (ROA) is 3.25%. These figures are below the industry median for Commodity Chemicals, indicating that the company is underperforming in terms of capital efficiency and asset utilization. The company's revenue is primarily concentrated in the chemical manufacturing and distribution business, with no disclosed segment breakdown. Geographically, IVP Limited is focused on the Indian market, with manufacturing plants in Tarapur and Bengaluru. There is no indication of significant international exposure or diversification. Looking at the growth trajectory, IVP Limited's revenue for the latest fiscal year is 5.39 billion INR. While the company has a free cash flow of 112 million INR, the negative operating cash flow and capital expenditure of -48.1 million INR suggest that the company is investing in its operations. The outlook for the next fiscal year is not explicitly provided, but the company's performance will depend on its ability to improve operational cash flow and manage capital expenditures effectively. The risk assessment for IVP Limited indicates a medium liquidity risk and a low dilution risk. The company has a negative net cash position after subtracting total debt, which could impact its financial flexibility. The dilution risk is low, and there are no immediate signs of share dilution pressure. The company's financial structure and operational performance will be key factors in assessing its long-term viability. Recent events and filings do not provide specific details on the company's strategic initiatives or financial performance beyond the disclosed financials. The company's subsidiaries and business activities are primarily focused on the chemical manufacturing and distribution business, with no recent major events or significant changes in its business model.